Clinical Trial Update: Cardiovalve Transfemoral System - FIM Study [NA]

View source ↗

Summary

Enrollment by invitation is ongoing for the Cardiovalve Transfemoral System FIM study. The study targets patients with mitral regurgitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Snippet

Sponsor: Cardiovalve Ltd. | Conditions: Mitral Regurgitation | NA | Status: ENROLLING_BY_INVITATION